Parkinsons Disease Drug May Be Available Soon
A Long Beach trial reports L-dopa, also Jevadopa, showing strong improvement in 75 patients with Parkinsons disease. FDA expected to approve for prescription within weeks. Dr. Albert Kakkis notes 80 percent respond well, with significant gains in mobility and alertness after three to four months of treatment.
MENTIONED IN THIS ARTICLE
Long Beach
The
Food and Drug Administration
Albert Kakkis
St. Mary's Hospital
Kakkis
Observation of sexual side effects in Long Reach patients
A record notes two percent of patients on a four dose regimen show sexual desire changes, while Dr Kakkis states no hypersexuality phenomena have been seen among Long Reach participants.
MENTIONED IN THIS ARTICLE
Kakkis
Also Mentioned on This Page
Carlton
Lailton
Carton
Bource
United State Anvernment
Favre
Palm Springs
Los Angeles
Calif
Goode
Crite and Onvinc Sncramen
Finisry Saving Ageet
Roam
Arenes
E. Ocean Blvd
America
Fidelity Tde Savings
San Pedro
S. Western Ave
Stanton-Garden Grove
Beach Blvd
East Broadway
Glandalea
Fullerton
Santa Ang-Craigo
Sherman Oaks
Vom Nuys
Fassbank Accou
Tereyear Cartiforite Anessielta
Mater
Atlantic Ave
County Heart Assocision
California
Eutee Scte
ATCA